Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. Founded by Bruce Booth and Nello Mainolfi in 2017, Kymera Therapeutics is backed by investors that include BlackRock, Redmile Group, Bessemer Venture Partners, MRL Ventures Fund, and Atlas Venture and is headquartered in Cambridge.
FOUNDED:
2017
INDUSTRY:
Biotechnology, Health Care, Therapeutics
FOUNDERS:
Bruce Booth, Nello Mainolfi
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
